Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Journal of Cachexia, Sarcopenia and Muscle
Published in: Journal of Cachexia, Sarcopenia and Muscle 3/2014

01-09-2014 | Editorial

An invitation to the 2nd Cancer Cachexia Conference, Montréal, Canada

Authors: Denis Guttridge, Marion Couch, Sergio Di Marco, Imed E. Gallouzi, Nancy D. Zitzmann, Vickie Baracos, Michael Rudnicki, Michel Tremblay, Teresa Zimmers

Published in: Journal of Cachexia, Sarcopenia and Muscle | Issue 3/2014

Login to get access

Excerpt

The National Cancer Institute in the USA has recently placed greater emphasis on cancer cachexia research by identifying this syndrome as a provocative question needing to be addressed in order to drive progress against cancer. Such funding mechanisms are expected to stimulate cutting edge approaches at both the basic and clinical science levels to advance our understanding of the underlying causes of cachexia. The goal is to identify and test lead compounds that preserve the loss of adipose and skeletal muscle tissues in pancreatic and other tumor types prone to developing cachexia. …
Metadata
Title
An invitation to the 2nd Cancer Cachexia Conference, Montréal, Canada
Authors
Denis Guttridge
Marion Couch
Sergio Di Marco
Imed E. Gallouzi
Nancy D. Zitzmann
Vickie Baracos
Michael Rudnicki
Michel Tremblay
Teresa Zimmers
Publication date
01-09-2014
Publisher
Springer Berlin Heidelberg
Published in
Journal of Cachexia, Sarcopenia and Muscle / Issue 3/2014
Print ISSN: 2190-5991
Electronic ISSN: 2190-6009
DOI
https://doi.org/10.1007/s13539-014-0150-1

Other articles of this Issue 3/2014

Journal of Cachexia, Sarcopenia and Muscle 3/2014 Go to the issue

Editorial

Efforts begin to sprout: publications in JCSM on cachexia, sarcopenia and muscle wasting receive attention

Original Article

Identifying recreational physical activities associated with muscle quality in men and women aged 50 years and over

Letter to the Editor

Relationship between arterial stiffening and skeletal muscle atrophy in hemodialysis patients: a gender comparative study

Review

Osteosarcopenic obesity: the role of bone, muscle, and fat on health

Original Article

Assessing sarcopenic prevalence and risk factors in residential aged care: methodology and feasibility

Editorial

Resistance exercise: an effective strategy to reverse muscle wasting in hemodialysis patients?
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits